Skip to main content
B

BLAU FARMACÊUTICA S.A. — Investor Relations & Filings

LEI · 254900YP8DZ5SO4GQR53 SA Manufacturing
Open in API
Filings indexed 92 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country BR Brazil
Listing SA

About BLAU FARMACÊUTICA S.A.

Blau Farmacêutica S.A. is a multinational corporation specializing in the institutional and hospital segments. As a pioneer in the development of biological products, the company develops and manufactures a diverse portfolio of high-complexity medications, including biologics, oncologicals, antibiotics, anesthetics, and antirheumatics. Its product range also encompasses specialized treatments for feminine health and uterine stimulation. The organization maintains a strong focus on research and development, utilizing proprietary manufacturing facilities to deliver advanced therapeutic solutions. With an international presence, the company provides high-quality medical products designed to meet the rigorous demands of healthcare institutions and specialized hospital environments.

Recent filings

Filing Released Lang Actions
Relatório Anual do Agente Fiduciário Exercício de 2025
Regulatory Filings
2026-04-29 Portuguese
-
Governance Information Classification · 1% confidence The document is the Estatuto Social (company bylaws) of Blau Farmacêutica S.A., detailing the company’s internal governance rules, corporate structure, objects of business, and subsidiary information. This is a governance charter rather than a financial report or an announcement. It falls squarely under Governance Information (CGR).
2026-04-22 Portuguese
Mapa Final de Votação Detalhado
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled “Assembleia Geral Ordinária e Extraordinária realizada em 22 de abril de 2026” and consists of detailed “Mapas Finais de Votação” (Final Voting Maps) showing vote counts for each agenda item at the shareholder meetings. It reports the official results of shareholder votes on approval of financial statements, allocation of earnings, remuneration of administrators, and bylaws amendments. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-04-22 Portuguese
Tomada de Contas-Votação do Relatório da Administração e das Demonstrações Financeiras; Remuneração dos Administradores e Conselheiros; Destinação dos Resultados; Reforma Estatutária
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is the official “Ata da Assembleia Geral Ordinária e Extraordinária” (minutes of the Ordinary and Extraordinary Shareholders’ Meeting) held on April 22, 2026. It includes detailed vote counts, resolutions taken on financial statements, dividend distribution, capital increase, and statute amendments. This corresponds to the category for declaration of shareholder vote results at a general meeting. Hence, it should be classified as a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-04-22 Portuguese
AGOE - Mapa sintético consolidado
Regulatory Filings
2026-04-20 Portuguese
DFP 2025
Regulatory Filings
2026-03-17 Portuguese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.